Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Scientists led by Ali Erturk at Ludwig Maximilians University in Munich have developed a technique that uses a solvent to make organs such as the brain and kidneys transparent. The organ is then scanned by lasers in a microscope that allows researchers to capture the entire structure, including the blood vessels and every single cell in its specific location. Using this blueprint, researchers print out the scaffold of the organ. They then load the 3D printer with stem cells which act as “ink” and are injected into the correct position making the organ functional. While 3D printing is already used widely to produce spare parts for industry, Erturk said the development marks a step forward for 3D printing in the medical field. Until now 3D-printed organs lacked detailed cellular structures because they were based on images from computer tomography or MRI machines, he said. “We can see where every single cell is located in transparent human organs. And then we can actually replicate exactly the same, using 3D bioprinting technology to make a real functional organ,” he said. “Therefore, I believe we are much closer to a real human organ for the first time now.”  Erturk’s team plan to start by creating a bioprinted pancreas over the next 2-3 years and also hope to develop a kidney within 5-6 years. The researchers will first test to see whether animals can survive with the bioprinted organs and could start clinical trials within 5-10 years, he said. Claim: German scientists create see-through human organs.
[A]: Researchers in Germany have created transparent human organs using a new technology that could pave the way to print three-dimensional body parts such as kidneys for transplants.


[Q]: Paragraph: “Johnny carries a lot of clout in our league when you hear the other coaches,” Brey said as he prepares for his 20th season at Notre Dame. “We take him for granted - he just rolls out of bed and goes 15 (points) and 12 (rebounds) like it’s nothing.” The 6-foot-9 senior Mooney averaged team highs of 14.1 points and 11.2 rebounds last season for the Fighting Irish, who lost 63 games to injuries and illnesses during a 14-19 campaign that included just three wins and a last-place finish in the Atlantic Coast Conference. “They had their back sides handed to them . we’re older, we’re healthier, we’re better,” Brey said. The return to health of guards Robby Carmody, Rex Pflueger, Nikola Djogo and forward Juwan Durham, the maturation of sophomores Prentiss Hubb, Dane Goodwin, Nate Laszewski and Chris Doherty, and senior T.J. Gibbs making amends for his junior slump have created excitement for the season opener Nov. 6 at North Carolina. “The guys are playing at a higher level, sharing the basketball and feeding off each other,” Mooney said. “Coming off last year, no one’s giving us a shot. So we have to play with a chip on our shoulder to get the job done and prove these people wrong.” Hubb, who started 29 games at point guard, thinks Mooney’s leadership is just fine, even if his coach would like more confidence from his standout. “He’s a role model for everyone on this team,” said Hubb, who averaged 8.1 points and nearly four assists last season. RALLYING AROUND REX Things went south quickly for the Irish after Pflueger, averaging 8.1 points and 4.7 rebounds at the time, tore left knee ligaments last December. The injury came at the same time his mother was diagnosed with brain cancer. She died early in September and the team attended her memorial service in California. “Some of the stuff they’ve gone through with Rex and his mother’s situation — that’s kind of done some things to our team’s dynamic,” Brey said. “It speaks highly of our coaching staff and players,” said Pflueger, now a grad student working on his MBA who is not being rushed to be ready for the opener. “It’s an act of kindness you don’t see often.” MEDIC In addition to Pflueger missing the final 23 games following knee surgery, Carmody missed his final 24 and Djogo his final six with torn labrums that were surgically repaired. The 6-foot-11 Durham, who missed six games with leg issues, averaged 2.3 blocks when healthy in 27 games. THE HUBB Brey likes what he sees in the 6-foot-3 Hubb at the point. “He moves more confidently and is more vocal,” Brey said. “He and T.J. (Gibbs) have been pretty good.” BEAT THE CLOCK Instead of the usual 30-second shot clock, Brey used a 20-second version during the preseason. “That way we have to play quick and you can’t think too much. You’ve got to make a decision,” he said. SCHEDULE Besides North Carolina, the Irish host Boston College on Dec. 7 in the pre-holiday portion of the 20-game ACC schedule. Notre Dame also has non-conference games with Maryland, UCLA and Indiana before starting the final 18 games of league play at Syracuse Jan. 4. Brey said he and Orange coach Jim Boeheim talked about the league’s big three — North Carolina, Duke and defending champion Virginia — on the summer scouting trail. “He said, ‘You know, we’re all playing for fourth,’” chuckled Brey, whose team is picked seventh. “He never minces words, obviously.” __ More AP college basketball: https://apnews.com/Collegebasketball and https://twitter.com/AP_Top25 Claim: Mooney and healthy teammates have Brey, Irish encouraged.
[A]: As long as John Mooney keeps putting up double-doubles and his teammates stay healthy, coach Mike Brey feels pretty good about Notre Dame’s chances this season.


[Q]: Paragraph: "The story listed the cost per unit for all three creams. The story didn’t provide the numbers from a cited 1994 study on capsaicin benefits. Overall, the message of ""no good evidence"" was clear. But, confusingly, the story gave the last word to a rheumatologist who said some of these creams ""do seem to help some people…it can give you temporary relief."" If you’re going to do that, we think you need to provide numbers. How many people? How long is temporary? To end the story in this way – without numbers to back up this flip-flop of a message – was disappointing. The story was clear about lack of effectiveness overall – and that with the capsaicin cream, ""the burning sensation is often intolerable."" The story went right to the point:  ""there’s no good evidence that any over-the-counter rub or cream offers real relief for arthritis, Altman says. Very few high-quality studies have ever investigated the products, he says, and the results that do exist have been far from convincing."" There was no disease-mongering of the pain of arthritis. Two expert sources in rheumatology were interviewed. The story danced around the topic of a placebo effect without ever directly addressing it. And it didn’t make any direct comparison with aspirin or non-steroidal anti-inflammatory drugs or with heating pads or other options. The over-the-counter availability of the creams is clear in the story. The story offered this context:  ""Over the centuries, people have been willing to rub all sorts of things into their sore joints. Today, arthritis sufferers can choose from a wide range of over-the-counter creams with different approaches to relief."" By the end of the story it was clear that today’s creams may not offer much advancement over what’s been done with rubs through the centuries. It’s safe to assume that the story did not rely on a news release." Claim: Arthritis creams are probably better than goat tears
[A]:
"If you ever wondered about the evidence for those hot and/or smelly creams for arthritis pain, this column drove home a ""healthy skeptic"" perspective, emphasizing, for the most part, that ""there’s no good evidence that any over-the-counter rub or cream offers real relief for arthritis,"" according to one source. We say ""for the most part"" because it ended oddly, allowing some broad, vague, unsubstantiated and unquantified claims — ""seem to help some people…can give you temporary relief."" We also wish the column had given a glimpse of the regulatory oversight that allows claims like ""deep penetrating pain relief"" or ""proven clinical effectiveness in treating arthritis pain"" when the column itself kept repeating:   ""no good evidence""   ""results that do exist have been far from convincing""   ""no better than placebo""   ""relief was minor and didn’t show up until four weeks of treatment""  ""the effect is usually either too fleeting or too mild to notice""   ""there’s no known pathway they could take to ease arthritis pain."""